| Novo Nordisk A/S |
NVO
|
7 615 245 |
17.8 |
70 505 |
| Eli Lilly & Co |
LLY
|
6 448 530 |
15.1 |
8 282 |
| Roche Holding AG |
ROG.SW
|
2 139 856 |
5.0 |
7 426 |
| Zealand Pharma A/S |
ZEAL.CO
|
2 095 964 |
4.9 |
18 639 |
| AstraZeneca PLC |
AZN
|
1 812 449 |
4.2 |
26 979 |
| Chugai Pharmaceutical Co Ltd |
4519.T
|
1 787 353 |
4.2 |
39 200 |
| Viking Therapeutics Inc |
VKTX
|
1 611 570 |
3.8 |
34 509 |
| Amgen Inc |
AMGN
|
1 567 243 |
3.7 |
5 893 |
| Pfizer Inc |
PFE
|
1 490 599 |
3.5 |
56 398 |
| Innovent Biologics Inc |
1801.HK
|
1 481 210 |
3.5 |
318 000 |
| Altimmune Inc |
ALT
|
1 340 413 |
3.1 |
159 573 |
| Hanmi Pharm Co Ltd |
128940.KS
|
1 305 693 |
3.0 |
6 946 |
| Structure Therapeutics Inc |
GPCR
|
1 272 893 |
3.0 |
40 435 |
| Regeneron Pharmaceuticals Inc |
REGN
|
1 084 854 |
2.5 |
1 466 |
| Gubra A/S |
GUBRA.CO
|
1 031 506 |
2.4 |
10 352 |
| Terns Pharmaceuticals Inc |
TERN
|
971 849 |
2.3 |
142 919 |
| Gilead Sciences Inc |
GILD
|
849 398 |
2.0 |
9 153 |
| United Laboratories International Holdings Ltd/The |
3933.HK
|
828 781 |
1.9 |
566 000 |
| Scholar Rock Holding Corp |
SRRK
|
824 417 |
1.9 |
18 887 |
| Takeda Pharmaceutical Co Ltd |
TAK
|
821 640 |
1.9 |
61 500 |
| Shionogi & Co Ltd |
4507.T
|
733 475 |
1.7 |
52 200 |
| Rhythm Pharmaceuticals Inc |
RYTM
|
702 900 |
1.6 |
12 375 |
| Biohaven Ltd |
BHVN
|
632 296 |
1.5 |
16 163 |
| OPKO Health Inc |
OPK
|
566 552 |
1.3 |
351 896 |
| Caliway Biopharmaceuticals Co Ltd |
6919.TW
|
546 907 |
1.3 |
32 820 |
| Corcept Therapeutics Inc |
CORT
|
514 676 |
1.2 |
9 334 |
| CSPC Pharmaceutical Group Ltd |
1093.HK
|
502 810 |
1.2 |
844 000 |
| First American Government Obligations Fund 12/01/2031 |
FGXXX
|
121 684 |
0.3 |
121 684 |
| Keros Therapeutics Inc |
KROS
|
112 356 |
0.3 |
6 242 |
| Cash & Other |
Cash&Other
|
-7 294 |
0.0 |
-7 294 |
Wall Street Experts